Malin Corporation | MLC - 当期純利益

株価
7.95
毎日の変更
0 0%
毎月
3.25%
毎年
-6.47%
Q2 予測
7.71




当期純利益 変化する 日付
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
ALKERMES USD 49.34M 33.42M 2025-12
Avita Medical AUD -11.62M 1.7M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Eurofins Scientific SE EUR 193.7M 22.3M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Lonza CHF 426M 119M 2025-06
Malin Corporation EUR -1.1M 2.2M 2023-12
Moderna USD -200M 625M 2025-09
Organon & Co USD 160M 15M 2025-09
Ovoca Bio EUR -765K 4.89M 2025-06
Revvity USD 98.36M 51.71M 2025-12
Tectonic Therapeutic USD -19.23M 186K 2025-12
Viatris USD -340.1M 211.9M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12